La Vox Media Group launches Hispanic-centric health information site
MIAMI — La Vox Media Group on Monday launched Saludify.com, a site designed to provide Latinos with daily news and content to live a better life and improve their health. With a mission to improve the health and wellbeing of U.S. Latinos, Saludify is providing accurate, convenient and culturally relevant content that goes beyond what’s found in mainstream media.
The Hispanic community represents significant growth opportunity for self-care companies. DSN recently spoke to Nielsen’s Reny Diaz around the OTC opportunity. "With particular focus on OTC sales, domestically, we’re looking at $1.2 billion out of a total $11.6 billion [attributed to] Hispanics," Diaz said. "What’s interesting is there’s almost $1 billion in Hispanic growth potential in that category."
“With this new site we show our commitment to catapulting Latino health issues to the forefront of American dialogue. Saludify is another building block in our strategy to serve Latino interests in specific niches,” stated Emilio Sanchez, president of La VOX Media Group, parent company of Saludify and VOXXI.
“There is a clear lack of culturally relevant health and wellness information available for Hispanic Americans. Saludify will inform and educate Hispanics by providing the non-biased information, resources and tools for mindful and healthier living,” commented Sandra Silva, managing editor of Saludify.
Saludify has tapped a network of Latino health and fitness experts and bloggers to cover important topics, the latest feature being an infographic titled, “Are Hispanics doomed?” that presents relevant stats about Latino health challenges, as well as putting into perspective The Hispanic Health Paradox.
Hispanics are one of the fastest growing minorities in the United States − representing more than 16% of the country’s population − and are disproportionally affected by heart disease, cancer, unintentional injuries, stroke, diabetes, chronic liver disease, chronic lower respiratory disease, perinatal conditions and influenza among other conditions. Saludify’s motto is mind, body and alma (soul), which is in line with its mission to create content that is specifically tailored to this important and underserved demographic.
Saludify is part of the La VOX Media Group that owns VOXXI, the premier independent platform for Hispanic news, analysis and commentary that was launched last year to fill the Latino void in mainstream media.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
U.K.’s Infirst Healthcare raises $30 million-plus to feed European OTC cough-cold and analgesic launches
LONDON — The U.K.’s Infirst Healthcare on Monday announced it has successfully raised $32.1 million in new funds. The funding, from Invesco Asset Management managed funds, will be used for the launch of the company’s medicines into the cough-cold and analgesic consumer healthcare markets.
Infirst will launch its first product, a cocoa-flavored cough liquid, in Europe. "Cough-cold and pain are the largest and most prevalent conditions in the consumer health sector and represent an enormous opportunity for Infirst to bring innovation and efficacy to a market which has seen very few new products and only marginal innovation for decades," stated Manfred Scheske, Infirst CEO.
The North American rights to Infirst’s cough-related launch have been out-licensed to Pernix Therapeutics Holdings.
Infirst is also developing an ibuprofen-based product for the treatment of inflammatory pain, to which it has the global rights, the company noted.
SanMedica unveils new HGH-booster at Academy of Women’s Health’s Annual Congress
WASHINGTON — SanMedica International on Friday introduced its SeroVital-HGH, a new oral human-growth hormone booster formulated with women in mind, at the Academy of Women’s Health’s Annual Congress here.
"Research is revealing that growth hormone is a vital aspect of women’s health that could affect everything from obesity to skin and aging to sex drive," stated Gina Daines, SanMedica spokeswoman. "Many of the women’s health experts attending this conference have seen that research and are beginning to realize the huge potential increased HGH levels could have for the women in their care."
"We’ve been thrilled about the opportunity to share our research with the highly respected group of women’s healthcare providers who are attending the conference," added Amy Heaton, SanMedica director of Scientific Affairs. "The research behind SeroVital is not only revolutionary because it proves there’s an oral compound capable of increasing growth hormone levels naturally — without synthetic injections — but also because it was the first clinical trial of its kind to test a compound’s growth hormone boosting effects not just on young males, but on both men and women across an appropriately wide age range. We think it’s important to let women’s health experts know just how well women responded to the SeroVital complex."